|
|
I am a serial entrepreneur & human genetics/genomics expert with broad expertise in diagnostics technology development and commercialization. With a large-scale genomics and industry background, I've led strategy & execution of genomic based diagnostics and businesses. My experience combines deep technical knowledge and strong business acumen with a passion for transforming healthcare through genomics. As an accomplished genomics industry leader, I have led high-performing companies & teams to a variety of technology, acquisition, and commercial successes, raised >$200M in capital, developed >36 important new genomic products, assays, technology areas, platforms and diagnostics, and created >$2B in value. As a biotech executive, I have held senior management, C-level, executive, key advisor roles in first-mover biotech & diagnostics companies, including Amersham (genomics business acquired by GE Healthcare), Verinata (cell-free DNA NIPT test acquired by Illumina), Siemens, Roche, CellScape, Diagenode, Panomics (gene expression systems acquired by Affymetrix), Med BioGene (lung cancer test acquired by Precision Therapeutics), Iconix (genomic informatics acquired by Entelos) and others.